Applied Pharmaceutical Analysis 2024

 In-Person Event

October 7-9, 2024

Bristol Myers Squibb, Cambridge, MA


Regulated Bioanalysis Workshop - Monday, October 7, 2024

Discovery Bioanalysis and New Technologies Workshop - Tuesday, October 8, 2024

Mechanistic ADME Workshop - Wednesday, October 9, 2024 


APA 2024 Program

William Hwang APA2024


William Hwang, MD, PhD

Assistant Professor @ Harvard Medical School

Understanding the tumor microenvironment using multi-omics and spatial omics - Title TBA


Joe Rajaro APA2024 


Joe Rajarao, PhD, MBA

Senior Manager @ Accenture

Application of AI in Drug Development

Terry Van Vleet APA2024


Terry Van Vleet, PhD, DABT, FATS, ERT

Head of Investigative Toxicology and Pathology @ AbbVie

Prospects for New Approach Methodologies and Complex In Vitro Models to Reduce, Refine and Replace Animals in Drug Safety Testing 

Ruben Ayala 

Ruben Ayala, PhD

Lead Pharmacologist, Office of Study Integrity & Surveillance, FDA

Recent Data Integrity Findings in Bioresearch Monitoring

Audrey Arjomandi APA2024

Audrey Arjomandi, PhD

Principal Scientist @ Genentech

Development of Nonclinical Total Anti-drug Antibody (ADA) Assays to Support Zinpentraxin Alfa Reproductive Toxicology Studies

 Jason DelCarpini APA2024

Jason DelCarpini, PhD

Director, Bioanalytical and Molecular Assays @ Moderna

bioanalytical considerations for mRNA based therapeutics - Title TBA

Reilly Eason APA2024

Reilly Eason, PhD

Senior Scientist @ Merck

Basics of Machine Learning and its Applications in Drug Discovery

Yohei Kosugi

Yohei Kosugi, PhD

Associate Director @ Takeda

Bio-digital transformation  of proteomic analysis


Qiushi Liu, PhD

Scientist @ Takeda

Subcellular Pharmacokinetics/Pharmacodynamics Analysis Using Spatial Transcriptomics Technology - Title TBA

Lory Payne

Lori Payne, PhD

Executive Director of Business Development @ Alturas Analytics

"Space - the final microsampling frontier/ Mitra Device /Part II"

Jasleen Sodhi APA2024

Jasleen Sodhi, PhD

Associate Director @ Septerna

Recent developments in predicting CYP-independent metabolism - Title TBA

Sandhya Subash APA2024

Sandhya Subash, PhD

Pharmaceutical Chemistry, Research Associate @ Washington State University

Uncertainties and Opportunities in Predicting Non-CYP Mediated Drug Metabolism


Xiaomin Wang, PhD

Director @ BMS

Accelerator Mass Spectrometry (AMS) Applications for Supporting Clinical Development

Danice Wilkins APA2024 

Danice Wilkins, PhD

Senior Director, Laboratory Sciences @ Charles River Laboratories

CRO outcomes shared on regulatory audits - Title TBA

Xiaoyun Yang APA2024

Xiaoyun Yang, PhD

Principal Scientist @ Genentech

Implementation of Low Volume Sampling Technologies for PK and Biomarker Analysis: Technical and Logistical Challenges and Solutions

Long Yaun APA2024

Long Yaun, PhD

Director/Head of Bioanalytical Group @ Biogen

A Novel Hybridization LC-MS/MS Methodology for Bioanalysis of siRNA

Elaine Tseng


Elaine Tseng, PhD

Principal Scientist @ Pfizer

Prediction of Drug-Drug Interactions Involving Time-dependent P450 Inhibitors - Title TBA

Prakash Bolleddula 


Prakash Bolleddula, PhD

Clinical Pharmacology Expert - Team Lead  @ EMD Serono

Translation of Metabolic Clearance for Aldehyde Oxidase Substrates - title TBA

Sean Zhu


Sean Xiaochun Zhu, Phd

Scientific Director @ Takeda

A 'Missing' Trazpiroben Metabolite Observed As the Most Abundant Metabolite in Human Plasma and Urine

Li Chin Wong 


Li Chin Wong, PhD

Executive Director @ Prevail Therapeutics a susidiary of  Eli Lilly and Company

Measuring Endogenous and Trangene-expressed Protein Levels in Gene Therapy Bioanalytical and Biomaker Studies

APA 2024 Sessions

Regulated Bioanalysis Workshop

Session I: Regulatory Audits (M10) and an Industry Perspective on Audits

Session II: Advances in Sampling Strategies and Drug Delivery Innovations

Session III: Advances in Drug Modalities and Emerging Technologies for Characterization


Discovery Bioanalysis and New Technologies Workshop

Session I: Emerging Analytical and Bioanalytical Platform Technology

Session II: Novel Strategies to Advance Biotherapeutic Development

Session III: Latest Advances: Elisa/Cell-Based Assays/Hepatocytes tissue

Session IV: Recent Case Studies to Support New Modalities


Mechanistic ADME Workshop

Session I: Role of NonCYP enzymes in DDI

Session II: PK/PD Challenges of New Modalities: ADCs, in vivo Gene Therapies, and PROTACs

Session III: The importance of tracking missing metabolites/new technologies (covalent drugs)

Session IV: New Approaches to in Vitro ADME Assays for Improved Drug-Drug-Interaction and Clearance Predictions


 Join our Linkedin Group:


Regulated Bioanalysis


Mechanistic ADME


Click here to register for the APA 2024 conference.

APA 2023 will take place October 7-9, 2024

Bristol Myers-Squibb, Cambridge, MA


The Boston Society

The Boston Society (R) is an internationally-recognized NON-PROFIT organization dedicated to bringing the best scientific ideas to industrial practice through focused, timely workshops and conferences. 501(c)3


Sign Up Today!

Privacy Policy